Browsing by Author "Melaku Adal"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Characterization of Epidemiological Nutritional Immunological and Virological and Genetic Diversity Parameters in Hiv-Infected Individuals in Addis Ababa Ethiopia(Addis Ababa University, 2021-06-17) Melaku Adal; Beyene PetrosHIV prevalence in Addis Ababa is relatively high among the high risk population. The aim of the present study was to investigate epidemiological, nutritional, immunological, and virological factors and HIV-1 diversity in antiretroviral naïve HIV-infected adults in Addis Ababa. To optimize study site and participant selection, a sytematic review of the existing baseline information was done to determine the prevalence of HIV/AIDS, and the predisposing risk factors in Addis Ababa. Data relevant for the systematic review were collected from online databases. In addition, survey and surveillance reports, performance and project assessment findings were also collected and analysed. From February to August 2013, this cross-sectional study was conducted on samples of 594 HIV-1 infected ART-naïve adult study participants, from four hospitals in Addis Ababa. CD4+ T cell count, HIV RNA load, fasting serum glucose, hemoglobin, fasting serum triglyceride and total cholesterol concentrations were determined. HIV-1 RNA amplification and sequencing was performed on 60 plasma samples, and assembled using the iterative viral assembler method. REGA subtyping tool was used for scanning of recombination and subtyping. Prediction of coreceptor usage was performed using online tools and phylogenetic analysis done using MEGA. The Spearman correlation, chi-square, Mann-Whitney and Kruskal-Wallis, independent t tests; ANOVA and regression analyses were used for data analysis. The prevalence of HIV in Addis Ababa appears to have stabilized at around 3%, but was higher in MARPs. The prevalence of undernutrition, excess weight, obesity and hypercholesterolemia were 15.1%, 22.1%, 5.4% and 16.6%, respectively. The hypercholesterolemia prevalence was higher in females (18.9%) than in males (11.0%) (p < 0.05). The median CD4+ T cell count was 2 357 cells/mm3(IQR = 248-537). Detectable HIV RNA load of 4.23 ± 0.83 log copies/mLwas found for a sample of 500 study participants. Serum total cholesterol and CD4+ T cell count were significantly correlated with HIV RNA load (p <0.01). Having lower concentration of serum total cholesterol was an independent predictor of higher HIV RNA load (p <0.05). The immune status was better in females than males in the presence of higher serum total cholesterol (p<0.05). Genome sequencing of the HIV isolates identified 81.7% subtype C, 1.7% subtype A1, and 10% C/A1 and 5.0% C/A1/D recombinants. PhenoSeq results to determine coreceptor usage from the 50 genome sequences were 88.0% and 12.0% that correspond to R5 and CXCR4, respectively. Furthermore, subtypes HIV-1 C and A1; CRFs C/A1 and C/A1/D, and R5-viruses were dominant. Therefore, nutritional abnormalities in the ART naïve HIV-infected study participants indicate the need for targeted nutritional programs and regular lipid level monitoring as an integral part of HIV/AIDS care. The more than 14% WHO clinical stage III/IV patients detected among the study participants, categorized as ART naïve, showed the need to revise the patient care policy on ART-naïve status of HIV positive individuals. The study also indicated the need for further indepth studies on HIV-1 subtype diversity, CRFs and its phenotypic distribution for a better understanding of the epidemiology of HIV/AIDS. Such indepth characterization of HIV-1 sub-type diversity will be required for possible future use of maraviroc, the co-receptor antagonist, in HIV/AIDS treatment.Item Comparison of the Genetic Variability of Human Immunodeficiency Virus Type 1 (HIV-1) In Blood Plasma and Cervicovaginal Lavage Using C2v3 Region of the Env Gene(Addis Ababa University, 2003-01) Melaku Adal; Kifle DagneTo investigate the characteristics of HIV-1 in the female genital tract and the molecular epidemiology of subtypes, cell-free viral populations in the blood plasma and vaginal mucosa of women infected with HIV-1 using DNA sequencing of C2V3 region of the env gene were examined. Study subjects were those who had visited a sexually transmitted disease clinic for genital tract inflammation (n = 32 of which 29 had sexually transmitted infections) in Addis Ababa, Ethiopia. From the study subjects, 28 of the blood plasma and 22 of the cervicovaginal lavage viruses were successfully amplified and sequenced. 31 of the subjects carried subtype C and only one subject carried subtype A. Among the total individuals carrying subtype C, 12 and 19 were with subclusters C and C’, respectively. The sequences in cervicovaginal lavage differed significantly from those in plasma. The number of nonsynonymous substitutions significantly exceeded synonymous substitutions in both plasma and cervicovaginal lavage in almost all the study subjects. Sequences from both compartments within an individual were more closely related to each other than to those obtained from viruses of other individuals when evaluated through phylogenetic analysis. However, there were significant genotypic differences between viruses in the two compartments of an individual. Differences in nucleotide sequences, in net charge of amino acids at physiological pH and predicted amino acid sequences were also observed. These differences could be due to selective immune pressures operating in the two compartments, which could lead to differential evolution of the viruses in vaginal mucosa and plasma that can lead to differential evolution of the viruses. These findings indicate that cellular replication of HIV-1 occurs in vaginal mucosa that results in a virus population with important differences from that in blood. This could result in different resistance patterns in the two compartments in the era of chemotherapies. Thus, resistance patterns in the viruses derived from the genital mucosa should be taken into account in order to prevent transmission of resistant viruses through exposure to the genital tract. For vaccine candidates, viruses derived from the genital compartment should be considered. So far, vaccine candidates are based on virus isolates from blood only. This indicates a need of considering all heterogeneity in all compartments to produce effective vaccines and therapies.